FDA Accepts Supplement Application for Acanya by Bausch
The FDA has accepted a supplemental application for Acanya, a topical acne treatment containing benzoyl peroxide and clindamycin phosphate.
Company
Pharmaceutical intelligence for Acne with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.